Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...

Top start-up accelerators for tech companies in 2025Issued by Emerging SoftwareJohannesburg, 14 Feb 2025Visit our press officeStart-up accelerators are intensive, short-term programmes designed to ...

The Crimson spoke to a range of commercial realtors, startup founders, and a commercial lab space owner to understand how the immense draw of Kendall Square has forced the myriad startup companies ...

Of the 11 new unicorns in January, five came from healthcare, including companies working on genetic research, drug ...

B.well Connected Health, maker of a platform unifying patient data, picked up an additional investment from nonprofit ...

Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...

Operator: Thank you for standing by, and welcome to the Origin Agritech Fiscal Year 2024 Conference Call. Please note that, today ...

Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.

In this post, I will focus on how companies around the world, and in different sectors, performed on their end game of ...

Eros Innovation, a multi-billion-dollar entertainment powerhouse revolutionizing the media business with artificial ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...